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Abstract
We report here two atypical cases of X-linked CGD patients (first cousins) in which cytochrome b558 is present at a normal
level but is not functional (X91). The mutations were localized by single-strand conformational polymorphism of reverse
transcriptase^polymerase chain reaction amplified fragments and then identified by sequence analysis. They consisted in two
base substitutions (C919 to A and C923 to G), changing His303 to Asn and Pro304 to Arg in the cytosolic gp91phox C-
terminal tail. Mismatched polymerase chain reaction and genomic DNA sequencing showed that mothers had both wild-type
and mutated alleles, confirming that this case was transmitted in an X-linked fashion. A normal amount of FAD was found
in neutrophil membranes, both in the X91 patients and their parents. Epstein^Barr virus-transformed B lymphocytes from
the X91 patients acidified normally upon stimulation with arachidonic acid, indicating that the mutated gp91phox still
functioned as a proton channel. A cell-free translocation assay demonstrated that the association of the cytosolic factors
p47phox and p67phox with the membrane fraction was strongly disrupted. We concluded that residues 303 and 304 are
crucial for the stable assembly of the NADPH oxidase complex and for electron transfer, but not for its proton channel
activity. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
In response to a wide range of stimuli, phagocytic
cells produce reactive oxygen intermediates which
have an important role in host defense. NADPH
oxidase from phagocytes and nonphagocytic cells
such as Epstein^Barr virus-immortalized (EBV) B
lymphocytes is responsible for superoxide O32 pro-
duction [1]. In resting cells, NADPH oxidase lacks
activity. Oxidase activation needs the assembly at
the membrane level of at least ¢ve di¡erent protein
factors. In fact, during the course of neutrophil
stimulation, the cytosolic factors p47phox,
p67phox/p40phox, and Rac1/2 translocate to the
plasma membrane and associate with cytochrome
b558 [2^7]. Cytochrome b558 is a hemoprotein con-
sisting of two K (p22phox) and L (gp91phox) sub-
units: this is the redox oxidase center and catalyzes
the electron transfer from NADPH to oxygen. It
binds two hemes [8]. Gp91phox functions as a £a-
vodehydrogenase and has certain sequence analogies
with the ferredoxin-NADP reductase (FNR) [9^
11], suggesting the presence of both NADPH and
FAD-binding domains, as demonstrated by photo-
labeling experiments [9,12,13].
Similar to mitochondrial cytochromes, gp91phox
conducts protons to compensate for the charge gen-
erated by electron transfer across the plasma mem-
brane [14,15]. The recent report showing that inward
H currents are absent in cells from an X910 patient
suggested that gp91phox behaves as an unusual H
channel that allows H in£ux and cytosolic acidi¢-
cation [16]. However, because the inward H cur-
rents did not correlate with oxidase activity, it was
recently proposed that gp91phox is not an H chan-
nel but instead modulates preexisting channels [17].
Expression of full-length or N-truncated gp91phox
and mutagenesis experiments were consistent with
gp91phox being the H channel itself [18^21]. Fur-
thermore, the recently cloned NADPH oxidase ho-
mologues NOX-1 and NOX-5 also function as H
channels [22,23]. H conduction was mapped to a
histidine repeat within the third transmembrane do-
main, with the central residue (His 115) being critical
for both H conduction and heme ligation [24]. This
suggests that, during oxidase assembly, structural
changes occur within the gp91phox cytochrome that
modulate its H channel activity and generate in-
ward H currents.
Chronic granulomatous disease (CGD) is a rare
inherited disorder in which phagocytic cells are un-
able to generate superoxide anions. Patients with
CGD are predisposed to recurrent bacterial and fun-
gal infections because of the absence of O32 -generat-
ing NADPH oxidase activity [25^27]. There are four
types of CGD that make up the autosomal forms
with mutations in the genes encoding p47phox,
p67phox, or p22phox proteins and the most common
X-linked CGD type (approximately 75%), with de-
fects in the CYBB gene encoding gp91phox where
cytochrome b558 is absent (X910) [28^31]. Several
types of mutations of gp91phox have been reported
in X-linked CGD, including deletional, insertional,
splicing, missense, nonsense, and duplicational muta-
tions [30]. In a very few rare cases, missense muta-
tions resulting in normal but nonfunctional levels of
cytochrome b558 have been identi¢ed (X91) [32^42].
Some of these have provided interesting information
about the NADPH oxidase structure and activation
mechanisms. Two of these X91 CGD patients had
missense mutations leading to substitutions (Arg54
to Ser and Ala57 to Glu) in the N-terminal region
of gp91phox, which a¡ect heme binding and/or stable
interaction with p22phox [32,33]. The other function-
al defects in the CYBB gene were related to muta-
tions in the C-terminal tail of gp91phox, which con-
tains the putative FAD and the NADPH binding
sites and cytosolic factor interaction domains [34^
37].
We report here two new CGD cases of the X type
identi¢ed in ¢rst cousins, whose neutrophils fail to
produce O32 but contain cytochrome b558. The func-
tional defect was identi¢ed as a double missense mu-
tation substituting His303 to Asn and Pro304 to Arg
in the gp91phox cytosolic C-terminal tail near the
putative FAD-binding domain. We demonstrate
that the reversal of charges in the cytochrome b558
disturbed the assembly of the NADPH oxidase com-
plex and is critical for the electron transfer from
NADPH to O2. In contrast, the mutated cytochrome
b558 has a normal FAD-binding capacity and is still
able to function as an H channel and to catalyze
cytosolic acidi¢cation.
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2. Materials and methods
2.1. Materials
Phorbol 12-myristate 13-acetate (PMA), formyl
methionyl leucyl phenylalanine (fMLP), and cyto-
chrome c (horse’s heart, type VI) were purchased
from Sigma Chemical Co. (St Louis, MO, USA).
Diisopropyl £uorophosphate (DFP) was purchased
from Sigma^Aldrich (Lisle d’Abeau Chesnes,
France). NADPH, avian myeloblastosis virus reverse
transcriptase, and Taq DNA polymerase were from
Roche Molecular Biochemical (Meylan, France). Re-
agents and molecular mass markers for SDS^PAGE
came from Amersham (Buckinghamshire, UK). Ni-
trocellulose sheets for Western blotting were pur-
chased from BioRad Laboratories (Richmond, CA,
USA). Trizol reagent was from Life Technologies
(Gaithersburg, MD, USA). Monoclonal antibodies
(mAbs) 449 and 48 were kindly provided by Drs.
Roos and Verhoeven in Amsterdam. The synthetic
peptide VITKVVTHPFKTIE (residues 296^309 of
the gp91phox sequence) and the peptide VIT-
KVVTNRFKTIE, containing the double substitution
as predicted in patient JR, were purchased from
Neosystem (Strasbourg, France) and were more
than 95% pure as controlled by high-performance
liquid chromatographic analysis. They were dissolved
in PBS to a concentration of 2 mM and kept at
320‡C.
2.2. Case report
Patient JR is a boy who, at the age of 9 months,
presented a reaction due to Calmette^Gue¤rin bacillus
with associated axillary lymphadenitis. When he was
8 years old he developed a liver abscess caused by
Staphylococcus aureus and CGD was diagnosed by
the absence of NBT reduction in neutrophils. A pro-
phylactic treatment with sulfamethoxazole, trimetho-
prime, and itraconazole was given, which prevented
new infections. To investigate the neutrophil re-
sponse in both parents, the NBT slide test was
used: it was normal in the father and gave intermedi-
ate values in the mother (50% of total neutrophils
were not able to reduce the NBT), both of them
being in good health. The ¢rst cousin (on the mater-
nal side) of the same age, patient VV, presented a
similar clinical story and CGD was also diagnosed at
8 years of age. His mother had the same NBT slide
test result as patient JR’s mother. The two boys are
now 16 years old.
2.3. Cell preparations
Human neutrophils and mononuclear cells (lym-
phocytes plus monocytes) were isolated from 25 ml
of citrated blood from patients JR and VV, their
parents, and normal volunteers as described [43],
after having obtained their informed consent. Lym-
phocytes from 5 ml of heparinized sterile venous
blood were collected by Ficoll^Hypaque density gra-
dient centrifugation and infected with the B95-8
strain of EBV as previously described [44]. The
EBV-B lymphocyte cell line was grown in RPMI-
1640 supplemented with 10% fetal calf serum, 100
U/ml penicillin, 50 Wg/ml kanamycin and 50 Wg/ml
streptomycin, at 37‡C in a 5% CO2 atmosphere.
2.4. Superoxide assay
NADPH oxidase activity of intact neutrophils was
assessed by measuring the rate of superoxide sensi-
tive cytochrome c reduction at 550 nm in presence of
SOD (O550 21.1 mM31 cm31) [44].
2.5. Preparation of RNA and DNA
Total RNA was isolated from both native mono-
nuclear cells and EBV-transformed B lymphocytes of
CGD patients as well as healthy donors, with a
modi¢ed single-step method described in [45] using
Trizol reagent.
Genomic DNA was puri¢ed from mononuclear
cells and EBV-transformed B lymphocytes of CGD
patients and normal subjects following classic proce-
dures [46].
2.6. cDNA ampli¢cation
First-strand cDNA synthesis was performed from
total RNA in 20 Wl containing RT bu¡er, using oli-
go-dT primers or for speci¢c reverse transcription
using primer 12* (Table 1) and a cDNA synthesis
kit according to the manufacturer’s instructions (Ap-
pligen Oncor, Illkirch, France). The cDNA was im-
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mediately ampli¢ed by PCR. In some experiments,
commercial actin primers were run in parallel with
PCR tests as a control for PCR and RNA extraction
e⁄ciency. Aliquots of 10-Wl PCR products in bromo-
phenol blue solution were run together with a scale
of DNA ladders (markers VI, Boehringer Mann-
heim, Meylan, France) on 1.5% (w/v) agarose gels
containing 1 Wg/ml ethidium bromide. The bands
were photographed under UV using Polaroid ¢lms.
2.7. Sequencing of the PCR products
PCR products were gel-puri¢ed and sequenced by
Genome Express, Grenoble, France, with forward
and backward primers using the Abi Prism auto-
matic sequencer (Perkin Elmer, Courtaboeuf,
France). PCR products were obtained from cDNA
or genomic DNA of patients JR and VV and their
parents from native mononuclear cells and from
EBV-B lymphocyte cell lines.
2.8. SSCP analysis
RT^PCR products were diluted twice with SSCP
loading bu¡er (20 mmol/l EDTA, 90% (v/v) form-
amide, 0.1% (w/v) xylene cyanol, 0.1% (w/v) bromo-
phenol blue); they were denatured at 95‡C for 5 min
and then chilled on ice [47]. The samples were
loaded onto a nondenaturing 10% acrylamide gel
containing 5% (w/v) glycerol, 0.5U TBE (50 mM
Tris^borate, 1 mM EDTA, pH 8) and submitted
to electrophoresis at 5 W, and 18‡C for 18 h in a
BioRad Dcode Universal mutation detection sys-
tem. The gel was silver stained according to the
manufacturer’s instructions.
2.9. Mismatch PCR
Genomic DNA puri¢ed from peripheral blood
mononuclear cells or EBV-immortalized B lympho-
cytes was ampli¢ed using two pairs of speci¢c prim-
ers. One pair of oligonucleotides was composed of a
forward primer 13, which is complementary to the
wild-type sequence of gp91phox cDNA, and a back-
ward primer 15*. The other pair consisted of primer
14, which is complementary to a mutant sequence of
gp91phox cDNA, and primer 15* (see sequences of
primers in Table 1).
2.10. Cytochrome b558 spectroscopy
Puri¢ed neutrophils treated by 3 mM diisopropyl
£uorophosphate were lysed for cytochrome b558 ex-
traction with a bu¡er containing 1% (w/v) Triton X-
100, 10 mM HEPES, 3.5 mM MgCl2, 1 mM PMSF,
0.1 mM leupeptin, 1 mM EGTA, and 1 mM EDTA,
pH 7.4. After 20 min incubation at 4‡C, the lysate
was centrifuged at 20 000Ug for 30 min [48]. The
supernatant was used for the immunoblotting experi-
ment and cytochrome b558 spectroscopy. Reduced
minus oxidized di¡erential absorption spectra were
recorded at room temperature with a DU 640 Beck-
man spectrophotometer [49]. A molecular extinction
coe⁄cient of O426ÿ410 nm = 200 mM31 cm31 for the
Soret band was used for calculations.
2.11. Determination of £avin content in membranes
Neutrophil membranes were diluted in a 50 mM
sodium/potassium phosphate bu¡er. The membrane
suspension was boiled for 3 min, then put on ice to
liberate FAD. After centrifugation, the supernatant
Table 1
Sequence of oligonucleotide primers used for the PCR ampli¢-

















16 GAAAAATGTCATTTCCAGACATATG Intron 8
Pairs of oligonucleotides (1,2*), (3,4*), (6,7*), (9,10*), (11,12*)
were used as primers for PCR ampli¢cation and SSCP analysis.
Pair (5,8*) was also used in this experiment, except that the
PCR product was digested with restriction enzyme MaeIII. Oli-
gonucleotides 13, 14, and 15* were used as primers for mis-
match PCR and primers (16,7*) for PCR ampli¢cation of exon
9’s part from genomic DNA. *Anti-sense strand.
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was diluted twice in 0.2 M borate bu¡er (pH 9), and
0.5 mU phosphodiesterase was added to generate
FMN from FAD in a ¢nal volume of 100 Wl at
room temperature. In 10 min, FAD was totally hy-
drolyzed in FMN. After 15 and 30 min of hydrolysis,
aliquots were analyzed for FMN by chemilumines-
cence reaction in a medium containing 70 WM 2-mer-
captoethanol, 50 WM decylaldehyde, and 100 WM
NADH in 50 mM phosphate bu¡er, pH 6.8 [50].
Desalted luciferase was added and RLU counts
were monitored at 30‡C in a Luminoscan luminom-
eter (Labsystems, Helsinki, Finland) coupled with a
computer. A standard curve in the range of 0.1^100
pmol of FMN was performed. We were able to mea-
sure the amount of membrane-bound FAD in 5.105
cell-equivalent accurately using this method. The
amount of FMN measured without addition of phos-
phodiesterase was less than 4% of total £avins.
2.12. Cytosolic pH measurements
EBV-transformed B lymphocytes were suspended
at a concentration of 2U106 cells/ml in Na medium
(150 mM NaCl, 1 mM KCl, 5 mM HEPES, 5.5 mM
glucose, pH 7.3), incubated with 5 WM BCECF-AM
for 20 min at room temperature, centrifuged (5 min at
1000 rpm), and resuspended in the Na medium. H
channel activity was assessed as described [19] by
measuring BCECF ratio £uorescence, using a Jasco
CAF-110 £uorescence spectrometer (Hachioji City,
Japan) and alternate excitation at 490 and 455 nm.
To prevent Na/H exchange and NADPH oxidase-
mediated acidi¢cation and to clamp the membrane
potential, 0.3 mM amiloride, 5 WM DPI, and 2.7
WM valinomycin were included. The H channel
was then activated by arachidonic acid (8 WM) and
an inward proton gradient was imposed by adding 10
mM HEPES in order to decrease the extracellular pH
to 6.6. At the end of the experiment, 50 WM CCCP
was added to equilibrate the cytosolic pH (pHi) with
the external pH, and a calibration curve was per-
formed to convert the ratio traces into pHi values.
2.13. Cell-free superoxide-generating system
NADPH oxidase activity was reconstituted
through a homologous cell-free assay [44]. Brie£y,
neutrophil membranes (30 Wg) were mixed with cy-
tosol (300 Wg) in PBS bu¡er containing 20 WM
GTPQS, 5 mM MgCl2 and arachidonic acid in a ¢nal
volume of 100 Wl. Peptides (296^309 and 491^504) at
a ¢nal concentration from 0 to 60 WM were added in
the medium of cell-free assay 2 min before addition
of arachidonic acid as described in [36]. A prelimi-
nary assay was performed to determine the optimal
amount of arachidonic acid necessary to provide
maximal oxidase activation. After incubation for 10
min at 25‡C, the oxidase activation medium was
transferred into a spectrophotometric cuvette con-
taining 100 WM cytochrome c, and the reaction was
then initiated with 150 WM NADPH (¢nal volume
1 ml).
2.14. Cytosolic protein translocation in the
cell-free system
Plasma membranes and cytosol were obtained
from puri¢ed neutrophils as described before [49].
NADPH oxidase activity was reconstituted through
a homologous cell-free assay. Brie£y, neutrophil
membranes (30 Wg) were mixed with cytosol (300
Wg) in oxidase bu¡er as described in [36]. SDS (100
WM) and GTPQS (10 WM) were added (¢nal volume
1 ml) and after 10 min at room temperature the
mixture was loaded on a discontinuous sucrose gra-
dient. After centrifugation (1 h, 30 000 rpm, in an
SW41 rotor (Beckman) at 18‡C), the membranes
were collected between the two 45% and 20% (w/v)
sucrose layers and analyzed by immunoblotting with
speci¢c antibodies directed against cytosolic proteins
as described in the following section.
2.15. SDS^PAGE and immunoblotting
Proteins solubilized in a 1% Triton X-100 from
neutrophils were separated by SDS^PAGE in 10%
(w/v) acrylamide gel with a 5% (w/v) stacking gel
[51], electrotransferred to nitrocellulose [52] and im-
munodetected by monoclonal antibodies mAbs 449
and 48 directed against p22phox and gp91phox, re-
spectively [53], or polyclonal anti-peptide antibodies
directed against p47phox and p67phox proteins [54].
Detection was mediated with HRP-labeled goat anti-
rabbit or anti-mouse IgG followed by a chemilumi-
nescence reaction. The ¢lm’s exposure was less than
1 min.
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2.16. Protein determination
The protein content was estimated using the Brad-
ford assay [55].
3. Results
3.1. CGD diagnosis of patients JR and VV
The neutrophils of patient JR, stimulated with
PMA and fMLP, showed no respiratory burst as
measured by the SOD-sensitive cytochrome c reduc-
tion assay (Table 2). Neutrophils from JR’s father
had a normal NADPH-oxidase activity and those
from his mother gave intermediate values. Neutro-
phils from the ¢rst cousin, patient VV, and his par-
ents showed similar results (data not shown). The
NBT-slide test con¢rmed previous observations and
the mode of inheritance supported an X-linked mu-
tation. To determine the X-linked CGD type in pa-
tient JR, we measured the cytochrome b558 content of
a 1% Triton X-100 soluble extract (50 Wg of proteins
in each sample) from neutrophils using reduced mi-
nus oxidized di¡erence spectroscopy. As illustrated
in Fig. 1A, the di¡erential spectrum revealed a nor-
mal amount of cytochrome b558 (110 pmol/mg) in
patient JR’s neutrophils, similar to the neutrophil
membrane extract’s spectrum from a healthy donor
(140 pmol/mg (curve b versus curve a)) and in con-
trast to the spectrum of X0 CGD neutrophils in
which the Q, L, and K peaks of cytochrome b558
were absent (Fig. 1, curve c).
The presence of membrane components of the
NADPH oxidase complex was demonstrated through
an immunodetection experiment (Fig. 1B) using an
identical amount of 1% soluble extract from puri¢ed
neutrophils in all samples (50 Wg). We illustrated the
presence of cytochrome b558 in patient JR (lane 2)
and his parents’ neutrophils (the mother in lane 3
and the father in lane 4), as shown by the two
Table 2
NADPH oxidase activity in intact neutrophils from the X91
CGD patient JR and his parents





Patient JR 0 0
Patient JR’s mother 6.0 9.4
Patient JR’s father 13.3 23.3
Control (n = 5) 10.8 þ 3.1 17.8 þ 2.5
Neutrophils (1U106 cells in PBS) were stimulated with PMA
(20 ng/ml) or with fMLP (1037 M) and O32 generation was de-
termined by superoxide dismutase-inhibitable cytochrome c re-
duction assay, as described in Section 2. Control data represent
mean þ S.D. (n = 5).
Fig. 1. Reduced minus oxidized di¡erence spectra and immunodetection of cytochrome b558 in neutrophils from the X91CGD patient
JR and his parents. The experiment was performed on 1% Triton X-100 soluble extract of neutrophils (50 Wg) at room temperature.
The absorption pro¢le of reduced minus oxidized spectra is shown for a healthy donor (a), X91 patient JR (b), and X910 patient
AF (c) from the top (A). Fifty Wg of the same 1% Triton X-100 soluble extract from control neutrophils (lane 1), patient JR’s neutro-
phils (lane 2), his mother’s neutrophils (lane 3), his father’s neutrophils (lane 4), from X910 CGD patient AF (lane 5), and from con-
trol neutrophils again (lane 6), were subjected to SDS^PAGE and blotted onto a nitrocellulose sheet (B). K and L subunits of cyto-
chrome b558 were revealed with monoclonal antibodies mAb 449 (K) and mAb 48 (L). This result represents one experiment in ¢ve.
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K and L subunit bands. The speci¢city of the mono-
clonal antibodies directed against the two gp91phox
subunits was demonstrated by the absence of
gp91phox and p22phox in the X0CGD-soluble ex-
tract, seen in lane 5, as compared to the control
neutrophil extract (lane 6). A similar experiment
was performed with the cytosolic factors p67phox,
p47phox, and p40phox, giving an identical ratio in
all the samples (data not shown). The results suggest
that the phenotype was compatible with a mutation
located either in the gene encoding gp91phox and
leading to a nonfunctional cytochrome b558, as found
in the X91 CGD type, or with a defect at an un-
related locus on the X chromosome that encodes an
unknown protein critical to the function of NADPH
oxidase.
3.2. Genetic analysis of CGD patients JR and VV
SSCP analysis was performed to localize the mu-
tation in the mRNA encoding gp91phox. The con-
trol’s and the patient’s mRNAs were reverse-tran-
scribed into six overlapping cDNA fragments with
six pairs of oligonucleotide primers derived from
the gp91phox cDNA (Table 1) and were studied by
SSCP analysis. In only two of them migration was
abnormal (Fig. 2A,B). Fragment 1 (residues 812^
1087), obtained with primers 6 and 7* (Table 1)
and localized in exon 9 of the CYBB gene (Fig.
2A), demonstrated an abnormal electrophoretic mi-
gration shift for patient JR (lane 3) and for his ¢rst
cousin, patient VV (lane 4), compared to the control
(lane 2). The same fragment ampli¢ed from the
X0CGD patient AF with a nonsense mutation in
exon 9 (unpublished data) also had an abnormal
migration (lane 1). In order to ascertain this ¢rst
result, the migration of fragment 2 (residues 539^
1222), ampli¢ed with primers 5 and 8* (see Table
1), which include fragment 1’s sequence, was ana-
lyzed with the same procedure (Fig. 2B). This second
fragment also had an abnormal mobility shift for
patient JR (Fig. 2B, lane 2) compared to the migra-
tion of a fragment ampli¢ed from a healthy donor
(Fig. 2B, lane 1).
These two RT^PCR fragments from patient JR
and patient VV were gel-puri¢ed and sequenced
with two pairs of forward and backward oligonu-
cleotide primers. In both fragments, two base sub-
stitutions were similarly detected (C919 to A and
C923 to G), changing His303 to Asn and Pro304
to Arg, in the gp91phox cytosolic C-terminal tail,
in a region near the putative FAD-binding domain
(Fig. 3A). We also sequenced all the gp91phox
cDNA of patients JR and VV from the four other
fragments and we found no other point mutations.
The double mutation was also found in both strands
of the genomic DNA from patient JR and patient
VV by PCR ampli¢cation and sequencing, using
forward primer 16 derived from the intron 8 se-
quence end (Dinauer, personal communication)
and backward primer 7* localized in exon 9 (se-
quences seen in Table 1). As seen in Fig. 3B, patient
JR was hemizygous for the mutations as compared
to his father’s genomic DNA sequence. For his
mother, the double mutation was present in one of
the two alleles with the presence of both bases C
and A at position 919 and bases C and G at posi-
tion 923. The same results were obtained from pa-
tient VV and his parents. In parallel, 50 control
genomic DNA were checked and no mutations
were found, as for both patients’ fathers.
Fig. 2. SSCP analysis of the ampli¢ed gp91phox cDNA frag-
ments. (A) SSCP analysis of PCR-ampli¢ed fragment 1 ob-
tained with oligonucleotides (6,7*) from X910 CGD patient AF
with a nonsense mutation in a site very close to patient JR’s
mutations (lane 1, unpublished data), from a healthy donor
(lane 2), from patient JR (lane 3), and from patient VV (patient
JR’s ¢rst cousin) (lane 4). (B) SSCP analysis of the PCR ampli-
¢ed fragment 2 obtained with the oligonucleotides (5,8*). Frag-
ment 2 was digested with the restriction enzyme MaeIII just be-
fore electrophoresis, from a healthy donor (lane 1) and from
X91 CGD patient JR (lane 2). The sequence of fragment 1
(A) was enclosed in the sequence of fragment 2 (B). The arrow
indicates the shift of the cDNA fragments.
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Fig. 3. Analysis of mutations in gp91phox mRNA and in the CYBB gene. RT^PCR products were gel-puri¢ed and automatically se-
quenced by Genome Express, Grenoble, France, with forward and backward primers (5,8*) and (6,7*) (sequences seen in Table 1) as
described in Section 2. A double mutation was detected, changing His303 to Asn and Pro304 to Arg in the gp91phox cytosolic C-ter-
minal tail containing putative FAD- and NADPH-binding domains, as seen in A. RT^PCR products were obtained and sequenced
from patients JR and VV’s EBV-B lymphocytes and native mononuclear cells. Mutations were con¢rmed by genomic DNA PCR am-
pli¢cation and sequencing using the primers (16,7*) described in Table 1. ND, nondetermined nucleotide due to the presence at the
same position of two di¡erent bases.
Fig. 4. Mismatch PCR of genomic DNA from patient JR and his parents. Primers 14 and 15* were used in lanes 1, 3, 5, 7 and prim-
ers 13 and 15* in lanes 2, 4, 6, 8 (see Table 1 for sequences and positions). M, molecular markers. The PCR product was detected
only when primer 13 and primer 15* were used in genomic DNA prepared from peripheral blood mononuclear cells from the father
(lanes 5, 6) and from a healthy adult (lanes 7, 8). On the other hand, in genomic DNA from the patient’s mononuclear cells (lanes 1,
2), the PCR product was detected only when primer 14 and primer 15* were used. In genomic DNA from the mononuclear cells
from the mother (lanes 3, 4), the PCR product was detected when either primer 13 and primer 15* or primer 14 and primer 15* were
used. Mismatch PCR was also performed with puri¢ed genomic DNA from 50 healthy donors and no ampli¢cation occurred with
primers 14 and 15*. The same experiment was performed from genomic DNA from patient VV and his parents.
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To con¢rm that the mutated gene was transmitted
from the mother, genomic DNA mismatch PCR was
performed using wild-type or mutated forward prim-
ers (primers 13 or 14, respectively) and primer 15* as
the backward oligonucleotide (Table 1). As shown in
Fig. 4, in the case of genomic DNA prepared from
patient JR’s mononuclear cells (lanes 1 and 2), only
the combination containing the mutated primer
could produce a 255 bp band, while two 255 bp frag-
ments were produced from the mother’s DNA (lanes
3 and 4) with the two pairs of primers. Similarly, a
255 bp fragment was obtained only with the wild-
type primer from the father (lanes 5 and 6), as in
the control experiment (lanes 7 and 8). This result
con¢rmed that the mutated gene was transmitted
from the patient’s mother. The same experiment
was performed with genomic DNA from patient
VV and his parents and from EBV-B lymphocyte
cell lines, giving similar results (data not shown).
No double mutations were found in all the mismatch
PCRs made with control genomic DNA (50 control
alleles).
3.3. Determination of the £avin content of neutrophil
membranes
As the described double mutation was localized
upstream but near the putative FAD-binding do-
main, which begins at Leu335 according to informa-
tion deduced from sequence alignments of the cyto-
solic gp91phox C-terminal tail with members of the
ferredoxin-NADPH reductase family [9^11], we de-
cided to measure the FAD content of neutrophil
membranes (Table 3). The amount of FAD was
shown to be correlated with that of cytochrome
b558, as shown by the result of the X910 patient
(21.0 þ 4 pmol/mg protein) compared to controls
Table 3
FAD content in neutrophil plasma membranes
FAD
pmol/mg protein % of control
Control 97 þ 18 100
X0 CGD patient AF 21 þ 4 22
X CGD patient JR 84 þ 14 87
JR’s mother 105 þ 35 108
JR’s father 104 þ 10 107
Values represent the mean þ S.D. of triplicate determinations.
The amount of membrane-bound FAD was measured with
5U105 cell equivalent. Noncovalently bound FAD was mea-
sured by the chemiluminescence method described in Section 2.
Fig. 5. H channel activity in EBV-transformed B-lymphocyte
cell lines. Cytosolic acidi¢cation in response to an imposed pH
gradient was measured with BCECF, as described in Section 2.
Cells were incubated with amiloride, DPI, and valinomycin (2.7
WM) and H channel activity was initiated with arachidonic
acid (8 WM). An inward pH gradient was subsequently imposed
by adding 10 mM HEPES to the cell suspension in order to
clamp the extracellular pH to 6.6. Superimposed traces showing
cytosolic acidi¢cation in EBV-transformed B lymphocytes de-
rived from the three patients are shown in A. Cells from the
control (dark ¢lled circles) and the X91 patient (gray ¢lled
circles) rapidly acidi¢ed to levels close to the external pH. In
contrast, cells from the X910 patient (open circles) acidi¢ed
more slowly and remained more alkaline than the external pH.
The protonophore CCCP (50 WM) was added to equilibrate the
cytosolic pH with the external pH. Traces are representative of
eight di¡erent experiments. In B, the extent of cytosolic acidi¢-
cation measured 30 s after imposing the pH gradient is shown.
Data are mean þ S.E.M. from eight independent experiments,
performed on three di¡erent preparations of EBV-transformed
B lymphocytes.
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(97 þ 18 pmol/mg protein). The amount of FAD in
patient JR’s neutrophil membranes (84 þ 14 pmol/
mg protein) was as high as that of control mem-
branes and similar to that of neutrophil membranes
from his father (104 þ 10 pmol/mg protein) and his
mother (105 þ 35 pmol/mg protein). Identical results
were obtained with neutrophil membranes from pa-
tient VV and members of his family (data not
shown).
3.4. Cytosolic pH measurement in EBV-transformed
B lymphocytes
To assess whether the mutated gp91phox protein
could still function as a proton channel, we measured
cytosolic pH changes in EBV-transformed B lympho-
cytes derived from patient JR. To selectively measure
gp91phox H £uxes, the oxidase was activated with
arachidonic acid in conditions allowing only H in-
£ux, as described in [19]. An inward proton gradient
was imposed by a combination of valinomycin (to
clamp the membrane potential) and HEPES (to de-
crease the external pH to 6.6), and cytosolic pH
changes were measured with BCECF in the presence
of amiloride (to inhibit Na/H exchange) and DPI
(to prevent acid production by the oxidase). In these
conditions, a cytosolic acidi¢cation re£ects the oxi-
dase-associated H channel activity corresponding to
the inward H currents measured in patch-clamp
studies [16,17]. As shown in Fig. 5A,B, cells from a
control patient acidi¢ed rapidly upon addition of
HEPES, their cytosolic pH equilibrating within
2 min with the external pH (Fig. 5, dark ¢lled
circles). As expected from the lack of a gp91phox
H channel, cells from the X910 patient AF acidi¢ed
more slowly and their cytosol remained more alka-
line than the external pH throughout the experiment
(open circles). Cells from the X91 patient JR acidi-
¢ed with similar kinetics and to the same extent as
cells from the control patient (gray ¢lled circles), in-
dicating that the mutated cytochrome retained its H
channel activity and could still be activated by ara-
chidonic acid. This suggests that the motif required
for H transport is not a¡ected by the double muta-
tion in the gp91phox cytosolic C-terminal tail, con-
sistent with earlier observations in X91 patients [15]
and with expression studies of gp91phox truncated
mutants [20,21].
3.5. Translocation of p47phox and p67phox to
neutrophil membranes in a cell-free oxidase
reconstitution assay
To investigate the functional e¡ect of the double
substitution at residues 303 and 304 of gp91phox, we
checked the ability of the cytosolic factors to be
translocated to the membrane-bound cytochrome
b558, using an in vitro translocation assay. In a con-
trol experiment (Fig. 6), cytosolic activating factors
p47phox and p67phox translocated to neutrophil
membranes; this was fully dependent on the presence
of SDS and GTPQS. On the contrary, with the case
of patient JR, translocation of p47phox and p67phox
to neutrophil membranes was hardly detectable. In
addition, no translocation of the cytosolic factors
was detected when the fraction originated from an
X910 CGD patient, which con¢rms that in the ab-
sence of cytochrome b558 no translocation of
p67phox and p47phox could occur.
3.6. E¡ect of peptide 296^309 of gp91phox on
NADPH oxidase assembling
To determine whether the gp91phox mutated do-
main of patient JR’s neutrophils was directly in-
Fig. 6. Western blot analysis of neutrophil membranes isolated
after assembling using a cell-free activation assay. Patients or
control neutrophil membranes (30 Wg) were incubated with con-
trol neutrophil cytosol (300 Wg) in oxidase bu¡er at room tem-
perature. After 10 min of incubation in presence (+) or in ab-
sence (3) of 100 WM SDS and 10 WM GTPQS, membranes were
isolated from each incubation mixture by sucrose gradient cen-
trifugation and proteins were pelleted down with 20% TCA
(v/v) before solubilization in sample bu¡er. Ten percent SDS^
PAGE was then performed and fractionated proteins were blot-
ted onto nitrocellulose. The transferred proteins were incubated
with rabbit antisera raised against p47phox and p67phox and
immune complexes were revealed by chemiluminescence reac-
tion. This result is representative of three separate experiments.
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volved in the binding of the cytosolic factors
p47phox and p67phox, experiments with synthetic
peptides were performed. Two peptides were used
(¢nal concentration from 0 to 60 WM): one with a
normal sequence 296^309 (wild-type peptide) and the
other from the same region with the double amino
acid substitution (mutated peptide), mimicking the
mutation present in gp91phox of neutrophils from
patient JR. The e¡ect of these two peptides on
NADPH oxidase activity was tested in a cell-free
assay. No inhibition of NADPH oxidase activity
was observed with both (wild-type and mutated) pep-
tides. On the contrary, the peptide 491^504 used by
Leusen et al. [36] inhibited the NADPH oxidase ac-
tivity reconstituted in the same conditions (data not
shown).
4. Discussion
In this paper we report two identical rare X-linked
CGD cases in which cytochrome b558 is present at a
normal level as measured by immunoblotting and dif-
ference absorption spectra while neutrophils fail to
produce superoxide anions. Mutations were localized
by single-strand conformational polymorphism anal-
ysis of ampli¢ed cDNA fragments corresponding to
the gp91phox protein of CGD patients JR and VV.
Sequence analysis of the mutated cDNA fragment
showed two C-to-A and C-to-G base mutations at
positions 919 and 923, predicting amino acid substi-
tutions in the gp91phox cytoplasmic C-terminal tail at
residues 303 and 304: both mutations correspond to
the replacement of histidine by asparagine and of
proline by arginine. The double mutation was identi-
¢ed in gp91phox RNA and in the CYBB gene puri¢ed
from native mononuclear cells and from EBV-immor-
talized B lymphocytes of both patients. The muta-
tions were genetically transmitted from the DNA of
both mothers (who were sisters) and were localized in
exon 9. The resulting defective NADPH oxidase ac-
tivity originates from a rare X91 CGD type.
Fourteen other cases of X91 CGD have been
reported (for review see [1]) and sometimes the inac-
tivating mutations have provided interesting infor-
mation about oxidase activation mechanisms. Seven
of these X91 CGD cases have been studied for their
functional properties and ¢ve of them are localized in
the C-terminal tail of gp91phox. Recently Lausen
and colleagues [37] described four novel X CGD
mutations. Three of them (Cys369CArg,
Gly408CGlu, and Glu568CLys) substantially dis-
turbed the association of p47phox and p67phox with
the plasma membrane. Two of them, Cys369CArg
and Thr341CLys are located in the putative FAD-
binding domain of gp91phox. Apparently a strong
relationship exists between the gp91phox domains
involved in the electron transfer and the binding of
cytosolic factors. The missense mutation Asp-
500CGly, situated in the external loop at the 3P
end of gp91phox according to previous structural
studies [56], but not in the FAD or NADPH binding
sites, leads to a translocation defect of the cytosolic
factors to the membrane [36]. Surprisingly, a deletion
of amino acids 488^497 described in an XCGD
patient, which is indeed localized in this external cy-
tosolic loop, does not a¡ect cytosolic factor assembly
to the plasma membrane [35]. An X913 has been
described by Kaneda et al. [42] with a missense mu-
tation in a site very close to our double mutation,
changing Glu309 to Lys. In that case, the O32 pro-
duction was shown to be diminished and related to a
low amount of cytochrome b558 ; no information
about FAD content and cytosolic factor transloca-
tion was reported. In patients JR and VV, the mu-
tated region was localized in a site close to the pu-
tative FAD-binding domain of gp91phox. The FAD
content of neutrophil plasma membranes from both
patients and their parents was compared to values
obtained with control plasma membranes. A normal
amount of FAD was found in patient JR, his moth-
er, and his father (84 þ 14, 105 þ 35, and 104 þ 10,
respectively). These results are in accordance with
conclusions drawn from homology studies with fer-
rodoxin-NADP reductase [9^11], showing that
NADPH and FAD-binding domains are probably
localized in a region downstream of His303 and
Pro304. Moreover, the HPFT motif residues of
gp91phox, which belong to the putative FAD-bind-
ing site, has recently been shown to be a good can-
didate for binding FAD, highlighting an essential
role of His338 in this function [57]. This mutation
seemed to a¡ect the stability of the gp91phox subunit
because only one third of the heme was present in
the CGD patient while translocation of cytosolic
proteins p67phox and p47phox occurred normally.
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The mutations we report in this paper also provide
interesting observations regarding the H channel
function of gp91phox. Because the mutated cyto-
chrome retains the histidine motif critical for H
transport, the hemoprotein of both patients (JR
and VV) was expected to still function as an H
channel. As shown in Fig. 5, H conductance could
readily be detected in EBV-transformed B lympho-
cytes from patient JR. Surprisingly however, the mu-
tated cytochrome was still able to catalyze inward
H £uxes and to generate a cytosolic acidi¢cation
upon stimulation with arachidonic acid. In previous
patch-clamp studies [16,17], inward H currents were
observed in phagocytes only in conditions that allow
the assembly of a fully functional oxidase. Contrary
to the lack of inward H £uxes reported in cells from
an X910 patient [58], the presence of a normal cyto-
solic acidi¢cation in cells from patient JR, which are
not able to assemble a functional oxidase, indicates
that the mutated cytochrome is still fully functional
as an H channel. Thus, these results suggest that the
H channel function requires neither the assembly
nor the redox function of the oxidase, consistent
with gp91phox itself being a fully functional H
channel.
Although interactions among the cytosolic factors
and between these factors and the light chain of
cytochrome b558 p22phox, are well de¢ned (for re-
view see [2]), interacting domains between gp91phox
and the other proteins of the NADPH oxidase com-
plex are uncertain. The cell-free translocation of cy-
tosolic p47phox and p67phox to patient JR’s neutro-
phil plasma membrane was investigated and
compared to that obtained with neutrophil mem-
branes from a healthy donor. In control experi-
ments, assembling occurred normally (Fig. 6), while
in the CGD patients JR and VV, there was no trans-
location of the cytosolic activating factors despite
the presence of the redox component of NADPH
oxidase.
To investigate the direct implication of the mu-
tated region of gp91phox in the assembly process,
competitive experiments in the O32 -generating cell-
free system were carried out with wild-type and mu-
tated synthetic peptides corresponding to the se-
quence 296^309 of gp91phox. No inhibition of
NADPH oxidase activity was observed with either
(wild-type and mutated) peptide. On the contrary,
the peptide 491^504 used by Leusen et al. [36] inhib-
ited the NADPH oxidase activity reconstituted in the
same conditions (data not shown). This suggests that
Asp500 in gp91phox is directly implicated in the as-
sociation of cytosolic factors p47phox and p67phox
proteins with gp91phox and that the gp91phox mu-
tated region of patient JR is probably not directly
involved in the binding of the cytosolic factors, even
if this domain is crucial in the NADPH oxidase as-
sembling. The identi¢ed double missense mutation
leading to the transformation of an His to an Asp
and of a Pro to an Arg results in a change in the
amino acid residue charges; this could explain a con-
formational modi¢cation of gp91phox and the lack
of assembling.
Only one double missense mutation was reported
in the NCF2 gene encoding p67phox resulting in a
CGD disease [59]. In that case the patient was het-
erozygous for the double mutation according to the
genomic DNA analysis and the p67phox protein was
not expressed. This double missense mutation was
found in homozygous state when the corresponding
RT^PCR fragment was sequenced. Probably the
NCF2 second allele carried another mutation not de-
scribed by the authors, leading to an unstable
mRNA. A very rare (T. Shoshani, N. Basham, B.
Kerem, March 21, 1991) double missense mutation
was reported in the CFTR gene described in the
cystic ¢brosis (CF) mutation data base (www.genet.
sickkids;on.ca/cftr-cgi-bin) containing 996 described
mutations. In the latter observation, both mutations
were discovered together on six CF chromosomes,
from three unrelated Jewish CF families from Geor-
gia in eastern Europe. The CF children in these fam-
ilies were homozygous for these two mutations. We
can conclude that a double missense mutation can
occur but it seems to be very rare. At that time, we
did not know whether one of the two mutations in
the CGD patients JR and VV was a polymorphism
that had appeared quite recently. The probability
that both missense mutations occurred at the same
time is very low; the evidence of a polymorphism for
one mutation cannot be excluded and further experi-
ments are needed to address the question. However,
His303 and Pro304 seem to play an important role
in the NADPH oxidase activity because they are
preserved in all Nox analogs [60] except His303 in
Nox 5.
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